These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27830724)

  • 41. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
    Harada K; Ferdous T; Harada T; Ueyama Y
    Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucin 1 downregulation impairs the anti-necroptotic effects of glucocorticoids in human bronchial epithelial cells.
    Zhang H; Liu Q; Kong L; Xu S
    Life Sci; 2019 Mar; 221():168-177. PubMed ID: 30738043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin.
    Liang CH; Shiu LY; Chang LC; Sheu HM; Tsai EM; Kuo KW
    Chem Res Toxicol; 2008 Feb; 21(2):393-9. PubMed ID: 18078328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
    Manna SK; Gangadharan C
    Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
    D'Abronzo LS; Bose S; Crapuchettes ME; Beggs RE; Vinall RL; Tepper CG; Siddiqui S; Mudryj M; Melgoza FU; Durbin-Johnson BP; deVere White RW; Ghosh PM
    Oncogene; 2017 Nov; 36(46):6359-6373. PubMed ID: 28745319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.
    Della Corte CM; Ciaramella V; Di Mauro C; Castellone MD; Papaccio F; Fasano M; Sasso FC; Martinelli E; Troiani T; De Vita F; Orditura M; Bianco R; Ciardiello F; Morgillo F
    Oncotarget; 2016 Jan; 7(4):4265-78. PubMed ID: 26673006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting EP4 by curcumin through cross talks of AMP-dependent kinase alpha and p38 mitogen-activated protein kinase signaling: the role of PGC-1α and Sp1.
    Hann SS; Chen J; Wang Z; Wu J; Zheng F; Zhao S
    Cell Signal; 2013 Dec; 25(12):2566-74. PubMed ID: 23998949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor activity of solamargine in mouse melanoma model: relevance to clinical safety.
    Furtado RA; Ozelin SD; Ferreira NH; Miura BA; Almeida Junior S; Magalhães GM; Nassar EJ; Miranda MA; Bastos JK; Tavares DC
    J Toxicol Environ Health A; 2022 Feb; 85(4):131-142. PubMed ID: 34612163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Extraction, purification technology and antineoplastic effects of solamargine].
    Tang Z; Zhang Y; Li N; Xu L; Zhao B; Xiao W; Wang Z; Bi Y
    Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(16):2192-5. PubMed ID: 22097327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solamargine induces apoptosis associated with p53 transcription-dependent and transcription-independent pathways in human osteosarcoma U2OS cells.
    Li X; Zhao Y; Wu WK; Liu S; Cui M; Lou H
    Life Sci; 2011 Feb; 88(7-8):314-21. PubMed ID: 21163271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells.
    Kuo KW; Hsu SH; Li YP; Lin WL; Liu LF; Chang LC; Lin CC; Lin CN; Sheu HM
    Biochem Pharmacol; 2000 Dec; 60(12):1865-73. PubMed ID: 11108802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling.
    Chiang CF; Chao TT; Su YF; Hsu CC; Chien CY; Chiu KC; Shiah SG; Lee CH; Liu SY; Shieh YS
    Oncotarget; 2017 Mar; 8(13):20706-20718. PubMed ID: 28157701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin.
    Shiu LY; Chang LC; Liang CH; Huang YS; Sheu HM; Kuo KW
    Food Chem Toxicol; 2007 Nov; 45(11):2155-64. PubMed ID: 17619073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of MUC1 expression by indole-3-carbinol.
    Lee IJ; Han F; Baek J; Hisatsune A; Kim KC
    Int J Cancer; 2004 May; 109(6):810-6. PubMed ID: 15027113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
    Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
    Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MUC1 oncoprotein is a druggable target in human prostate cancer cells.
    Joshi MD; Ahmad R; Yin L; Raina D; Rajabi H; Bubley G; Kharbanda S; Kufe D
    Mol Cancer Ther; 2009 Nov; 8(11):3056-65. PubMed ID: 19887552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer.
    Kufe D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.